Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2427-2432

  Cohen, Michal ^a,b   Bachmatov, Larisa ^a,b   Ben Ari, Ziv ^a,b   Rotman, Yaron ^a,b   Tur Kaspa, Ran ^a,b,c   Zemel, Romy ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Liver Institute   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Alternative reading frame protein; HCV core protein; HCV F protein; Hepatitis C virus

Indexed keywords

ARF PROTEIN; CORE PROTEIN; HEPATITIS C ANTIBODY; PEGASIS; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TREATMENT OUTCOME; VIRUS GENOME;

ANTIVIRAL AGENTS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRAL CORE PROTEINS;

EID: 34547839691     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9630-2     Document Type: Article

References (23)

1. Forns X, Bukh J (1999) The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin Liver Dis 3:693-716
2. Smith DB, Davidson F, Simmonds P (1995) Hepatitis C virus variants and the role of genotyping. J Hepatol 23(Suppl 2):26-31
3. McHutchison JG, Poynard T (1999) Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 19:57-65
4. McHutchison JG, Gordon SC, Schiff ER, et al. (1998) Interferon α2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485-1492
5. Schalm SW, Weiland O, Hansen BE, et al. (1999) Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. Gastroenterology 117:408-413
6. Lindenbach BD, Rice CM (2001) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, pp 991- 1042
7. Hussy P, Langen H, Mous J, et al. (1996) Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 224:93-104
8. Yasui K, Wakita T, Tsukiyama-Kohara K, et al. (1998) The native form and maturation process of hepatitis C virus core protein. J Virol 72:6048-6055
9. Moradpour D, Englert C, Wakita T, et al. (1996) Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63
10. Brierley I (1995) Ribosomal frameshifting viral RNAs. J Gen Virol 76:1885-1892
11. Hahn CS, Cho YG, Kang BS, et al. (2000) The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276:127-137
12. Soguero C, Joo M, Chianese-Bullock KA, et al. (2002) Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol 76:9345-9354
13. Xu Z, Choi J, Yen TSB, et al. (2001) Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20:3840-3848
14. Varaklioti A, Vassilaki N, Georgopoulou U, et al. (2002) Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277:17713-17721
15. Walewski JL, Keller TR, Stump DD, et al. (2001) Evidence of a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7:710-721
16. Roussel J, Pillez A, Montpellier C, et al. (2003) Characterization of the expression of the hepatitis C virus F protein. J Gen Virol 84:1751-1759
17. Klemke M, Kehlenbach RH, Huttner WB (2001) Two overlapping reading frames in a single exon encode interacting proteins-a novel way of gene usage. EMBO J 20:3849-3860
18. Komurian-Pradel F, Rajoharison A, Berland JL, et al. (2004) Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40:900-909
19. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) cross curve. Radiology 143:29-36
20. Gosert R, Moradpour D (2002) Reading between the lines: evidence for a new hepatitis C virus protein. Hepatology 36:757- 760
21. Lohmann V, Körner F, Koch J-O, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in hepatoma cell line. Science 285:110-113
22. Bain C, Parroche P, Lavergne JP, et al. (2004) Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78:10460- 10469
23. Foy E, Li K, Wang C, et al. (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148